US Patent Issued to Korea Basic Science Institute on April 15 for "Composition comprising CYP4A-inhibiting compound as active ingredient for preventing or treating metabolic diseases" (South Korean Inventors)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,274,705, issued on April 15, was assigned to Korea Basic Science Institute (Daejeon, South Korea).

"Composition comprising CYP4A-inhibiting compound as active ingredient for preventing or treating metabolic diseases" was invented by Gun Hwa Kim (Daejeon, South Korea), Min Ji Lee (Daejeon, South Korea), Koon Soon Kim (Daejeon, South Korea), Hyo Kyun Chung (Daejeon, South Korea), Ji Hoon Lee (Daejeon, South Korea), Se Jin Jung (Daejeon, South Korea) and Da Rong Kim (Daejeon, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a composition comprising a CYP4A-inhibiting compound as an active ingredient for preventing ...